Sanjivani Paranteral achieves robust Q2 FY25 growth with 29.5% revenue surge
Sanjivani Paranteral Ltd, a pharmaceutical powerhouse based in Mumbai, has announced remarkable financial results for Q2 of the fiscal year 2025, showcasing significant growth across revenue and profitability metrics. With a year-on-year revenue increase of 29.5%, the company has reinforced its leadership in manufacturing parenteral and oral solid products, particularly in therapeutic areas such as […]